Karan S Dixit (Karan Dixit)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 12

Top Topics

Silver Nanoparticles

Brain Metastases

Top Venues

Science advances

Neuro-oncology advances

This page only lists publications with an associated author ORCID identifier.

Publications

Katherine B Peters, Jessica Templer, Elizabeth R Gerstner, Thomas Wychowski, Anette M Storstein, Karan S Dixit, Tobias Walbert, Kaitlyn Melnick, Maya Hrachova, Sonia Partap, Nicole J Ullrich, Ashley P Ghiaseddin, Maciej Mrgula
Discontinuation of Antiseizure Medications in Patients With Brain Tumors. Neurology 102 (4) (2024)
Karan S Dixit, Lauren Singer, Sean Aaron Grimm, Rimas V Lukas, Margaret A Schwartz, Alfred Rademaker, M-Marsel Mesulam, Masha Kocherginsky, Sofia Chernet, Laura Sharp, Valerie Nelson, Jeffrey J Raizer, Priya U Kumthekar
A Phase II Trial of Bevacizumab in Patients with Recurrent/Progressive Solid Tumor Brain Metastases That Have Progressed Following Whole-Brain Radiation Therapy. Cancers 16 (11) (2024)
Riley K Driscoll, Seán B Lyne, David J Voce, Stefania Maraka, Vinai Gondi, Steven J Chmura, Karan S Dixit, Priya U Kumthekar, Theodore G Karrison, Peter Pytel, John M Collins, Roger Stupp, Ryan T Merrell, Rimas V Lukas, Bakhtiar Yamini
A multi-institutional phase I study of acetazolamide with temozolomide in adults with newly diagnosed MGMT -methylated malignant glioma. Neuro-oncology advances 6 (1) (2024)
Karan S Dixit, Lauren Singer, Sean Aaron Grimm, Rimas V Lukas, Margaret A Schwartz, Alfred Rademaker, M-Marsel Mesulam, Masha Kocherginsky, Sofia Chernet, Laura Sharp, Valerie Nelson, Jeffrey J Raizer, Priya U Kumthekar
A Phase II Trial of Bevacizumab in Patients with Recurrent/Progressive Solid Tumor Brain Metastases That Have Progressed Following Whole-Brain Radiation Therapy. Cancers 16 (11) (2024)
Katherine B Peters, Jessica Templer, Elizabeth R Gerstner, Thomas Wychowski, Anette M Storstein, Karan S Dixit, Tobias Walbert, Kaitlyn Melnick, Maya Hrachova, Sonia Partap, Nicole J Ullrich, Ashley P Ghiaseddin, Maciej Mrgula
Discontinuation of Antiseizure Medications in Patients With Brain Tumors. Neurology 102 (4) (2024)
Riley K Driscoll, Seán B Lyne, David J Voce, Stefania Maraka, Vinai Gondi, Steven J Chmura, Karan S Dixit, Priya U Kumthekar, Theodore G Karrison, Peter Pytel, John M Collins, Roger Stupp, Ryan T Merrell, Rimas V Lukas, Bakhtiar Yamini
A multi-institutional phase I study of acetazolamide with temozolomide in adults with newly diagnosed MGMT -methylated malignant glioma. Neuro-oncology advances 6 (1) (2024)
Ella N Perrault, Jack M Shireman, Eunus S Ali, Peiyu Lin, Isabelle Preddy, Cheol Park, Shreya Budhiraja, Shivani Baisiwala, Karan S Dixit, C David James, Dieter H Heiland, Issam Ben-Sahra, Sebastian Pott, Anindita Basu, Jason M Miska, Atique U Ahmed
Ribonucleotide reductase regulatory subunit M2 drives glioblastoma TMZ resistance through modulation of dNTP production. Science advances 9 (20) (2023)
Ella N Perrault, Jack M Shireman, Eunus S Ali, Peiyu Lin, Isabelle Preddy, Cheol Park, Shreya Budhiraja, Shivani Baisiwala, Karan S Dixit, C David James, Dieter H Heiland, Issam Ben-Sahra, Sebastian Pott, Anindita Basu, Jason M Miska, Atique U Ahmed
Ribonucleotide reductase regulatory subunit M2 drives glioblastoma TMZ resistance through modulation of dNTP production. Science advances 9 (20) (2023)
Ella N Perrault, Jack M Shireman, Eunus S Ali, Peiyu Lin, Isabelle Preddy, Cheol Park, Shreya Budhiraja, Shivani Baisiwala, Karan S Dixit, C David James, Dieter H Heiland, Issam Ben-Sahra, Sebastian Pott, Anindita Basu, Jason M Miska, Atique U Ahmed
Ribonucleotide reductase regulatory subunit M2 drives glioblastoma TMZ resistance through modulation of dNTP production. Science advances 9 (20) (2023)
Karan S Dixit, Sean Sachdev, Christina Amidei, Priya Kumthekar, Tim J Kruser, Vinai Gondi, Sean Grimm, Rimas V Lukas, Martin Kelly Nicholas, Steven J Chmura, Angela J Fought, Minesh Mehta, Jeffrey J Raizer
A multi-center prospective study of re-irradiation with bevacizumab and temozolomide in patients with bevacizumab refractory recurrent high-grade gliomas. Journal of neuro-oncology 155 (3) (2021)
Priya U Kumthekar, Caroline H Ko, Tatjana Paunesku, Karan S Dixit, Adam M Sonabend, Orin Bloch, Matthew Tate, Margaret Schwartz, Laura Zuckerman, Ray Lezon, Rimas V Lukas, Borko Jovanovic, Kathleen McCortney, Howard Colman, Si Chen, Barry Lai, Olga A Antipova, Junjing Deng, Luxi Li, Serena Tommasini-Ghelfi, Lisa A Hurley, Dusten Unruh, Nitya V Sharma, Manoj Kandpal, Fotini M Kouri, Ramana V Davuluri, Daniel J Brat, Miguel Muzzio, Mitchell Glass, Vinod Vijayakumar, Jeremy Heidel, Francis J Giles, Ann K Adams, C David James, Gayle E Woloschak, Craig M Horbinski, Alexander H Stegh
A first-in-human phase 0 clinical study of RNA interference-based spherical nucleic acids in patients with recurrent glioblastoma. Science translational medicine 13 (584) (2021)
Erik Ladomersky, Lijie Zhai, Kristen L Lauing, April Bell, Jiahui Xu, Masha Kocherginsky, Bin Zhang, Jennifer D Wu, Joseph R Podojil, Leonidas C Platanias, Aaron Y Mochizuki, Robert M Prins, Priya Kumthekar, Jeffrey J Raizer, Karan S Dixit, Rimas V Lukas, Craig Horbinski, Min Wei, Changyou Zhou, Graham P Pawelec, Judith Campisi, Ursula Grohmann, George C Prendergast, David H Munn, Derek A Wainwright
Advanced Age Increases Immunosuppression in the Brain and Decreases Immunotherapeutic Efficacy in Subjects with Glioblastoma. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (19) (2020)